HOXA9 and diffuse large B-cell lymphoma: Furthermore, our additional cohort (n = 79) with nine cases of BLS-type DLBCL also showed that DLBCL cases with HOXA9 overexpression carried a poorer prognosis (p = 0.028, Log Rank test, Supplementary Fig. S12).